KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Total Debt Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 10.34%
Dec 28, 2025 6.33%
Sep 28, 2025 29.49%
Jun 29, 2025 10.80%
Mar 30, 2025 13.63%
Dec 29, 2024 5.75%
Sep 29, 2024 4.12%
Jun 30, 2024 7.12%
Mar 31, 2024 2.75%
Dec 31, 2023 -0.76%
Oct 1, 2023 -0.87%
Jul 2, 2023 7.29%
Apr 2, 2023 10.21%
Jan 1, 2023 2.77%
Oct 2, 2022 -1.85%
Jul 3, 2022 -1.17%
Apr 3, 2022 0.48%
Jan 2, 2022 4.47%
Oct 3, 2021 4.68%
Jul 4, 2021 4.99%
Apr 4, 2021 7.56%
Jan 3, 2021 12.17%
Sep 27, 2020 -8.63%
Jun 28, 2020 9.50%
Mar 29, 2020 7.76%
Dec 29, 2019 8.10%
Sep 29, 2019 13.86%
Jun 30, 2019 11.43%
Mar 31, 2019 11.17%
Dec 30, 2018 10.89%
Sep 30, 2018 15.65%
Jul 1, 2018 16.45%
Apr 1, 2018 15.41%
Dec 31, 2017 16.43%
Oct 1, 2017 15.85%
Jul 2, 2017 14.50%
Apr 2, 2017 10.73%
Jan 1, 2017 6.69%
Oct 2, 2016 8.01%
Jul 3, 2016 6.98%
Apr 3, 2016 5.54%
Jan 3, 2016 3.44%
Sep 27, 2015 10.43%
Jun 28, 2015 10.63%
Mar 29, 2015 9.42%
Dec 28, 2014 5.23%
Sep 28, 2014 5.65%
Jun 29, 2014 4.69%